Dual role of quercetin in enhancing the efficacy of cisplatin in chemotherapy and protection against its side effects: a review

References

• Abdelkader, N.F., et al., 2020. New combination therapy of gliclazide and quercetin for protection against STZ-induced diabetic rats. Life sciences, 247, 117458.
   PubMed Web of Science ®Google Scholar
• Akca, G., et al., 2018. The protective effect of astaxanthin against cisplatin-induced nephrotoxicity in rats. Biomedicine & pharmacotherapy, 100, 575–582.
   PubMed Web of Science ®Google Scholar
• Aldemir, M., et al., 2014. Evaluation of the protective effect of quercetin against cisplatin-induced renal and testis tissue damage and sperm parameters in rats. Andrologia, 46 (10), 1089–1097.
   PubMed Web of Science ®Google Scholar
• Ali, A., et al., 2018. Quercetin induces cell death in cervical cancer by reducing O-GlcNAcylation of adenosine monophosphate-activated protein kinase. Anatomy & cell biology, 51 (4), 274–283.
   PubMed Web of Science ®Google Scholar
• Almaghrabi, O.A., 2015. Molecular and biochemical investigations on the effect of quercetin on oxidative stress induced by cisplatin in rat kidney. Saudi journal of biological sciences, 22 (2), 227–231.
   PubMed Web of Science ®Google Scholar
• Almeida, L.O., et al., 2014. NFκB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC). FEBS open bio, 4, 96–104.
   PubMed Web of Science ®Google Scholar
• Angeli, D., Salvi, S., and Tedaldi, G., 2020. Genetic predisposition to breast and ovarian cancers: how many and which genes to test? International journal of molecular sciences, 21 (3), 1128.
   PubMed Web of Science ®Google Scholar
• Armentano, B., et al., 2020. 5-(Carbamoylmethylene)-oxazolidin-2-ones as a promising class of heterocycles inducing apoptosis triggered by increased ros levels and mitochondrial dysfunction in breast and cervical cancer. Biomedicines, 8 (2), 35.
   Web of Science ®Google Scholar
• Arzuman, L., et al., .2014. Synergism from combinations of tris(benzimidazole) monochloroplatinum(II) chloride with capsaicin, quercetin, curcumin and cisplatin in human ovarian cancer cell lines. Anticancer research, 34 (10), 5453–5464.
   PubMed Web of Science ®Google Scholar
• Ashrafizadeh, M., et al., 2019. Autophagy, anoikis, ferroptosis, necroptosis, and endoplasmic reticulum stress: potential applications in melanoma therapy. Journal of cellular physiology, 234 (11), 19471–19479.
   PubMed Web of Science ®Google Scholar
• Atalik, K.E., et al., .2010. Vasoprotection by melatonin and quercetin in rats treated with cisplatin. Indian journal of experimental biology, 48 (12), 1188–1193.
   PubMed Web of Science ®Google Scholar
• Attia, S.M., 2010. The impact of quercetin on cisplatin-induced clastogenesis and apoptosis in murine marrow cells. Mutagenesis, 25 (3), 281–288.
   PubMed Web of Science ®Google Scholar
• Avan, A., et al., 2015. Platinum-induced neurotoxicity and preventive strategies: past, present, and future. The oncologist, 20 (4), 411–432.
   PubMed Web of Science ®Google Scholar
• Balakrishnan, S., et al., 2017. Gold nanoparticles-conjugated quercetin induces apoptosis via inhibition of EGFR/PI3K/Akt-mediated pathway in breast cancer cell lines (MCF-7 and MDA-MB-231). Cell biochemistry and function, 35 (4), 217–231.
   PubMed Web of Science ®Google Scholar
• Banik, K., et al., 2020. Piceatannol: a natural stilbene for the prevention and treatment of cancer. Pharmacological research, 153, 104635.
   PubMed Web of Science ®Google Scholar
• Behling, E.B., et al., 2006. Comparative study of multiple dosage of quercetin against cisplatin-induced nephrotoxicity and oxidative stress in rat kidneys. Pharmacological reports, 58 (4), 526–532.
   PubMed Web of Science ®Google Scholar
• Bielack, S.S., et al., 2008. Bone tumors in adolescents and young adults. Current treatment options in oncology, 9 (1), 67–80.
   PubMed Web of Science ®Google Scholar
• Bolouki, A., Zal, F., and Bordbar, H., 2019. Ameliorative effects of quercetin on folliculogenesis in diabetic mice: a stereological study. Gynecological endocrinology, 1–5. doi:10.1080/09513590.2019.1707796
   PubMed Web of Science ®Google Scholar
• Borska, S., et al., 2004. The effects of quercetin vs cisplatin on proliferation and the apoptotic process in A549 and SW1271 cell lines in in vitro conditions. Folia Morphologica, 63 (1), 103–105.
   PubMedGoogle Scholar
• Boyne, D.J., et al., .2020. Prognostic factors of adjuvant chemotherapy discontinuation among stage III colon cancer patients: a survey of medical oncologists and a systematic review and meta‐analysis. Cancer medicine, 9 (5), 1613–1627.
   PubMed Web of Science ®Google Scholar
• Brock, P. and Bellman, S., 1991. Ototoxicity of cisplatinum. British journal of cancer, 63 (1), 159–160.
   PubMed Web of Science ®Google Scholar
• Cai, H., et al., 2020. IFI16 promotes cervical cancer progression by upregulating PD-L1 in immunomicroenvironment through STING-TBK1-NF-kB pathway. Biomedicine & pharmacotherapy, 123, 109790.
   PubMed Web of Science ®Google Scholar
• Catanzaro, D., et al., 2015. Effect of quercetin on cell cycle and cyclin expression in ovarian carcinoma and osteosarcoma cell lines. Natural product communications, 10 (8), 1934578X1501000.
   Web of Science ®Google Scholar
• Chekenya, M., et al., 2008. The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling. Oncogene, 27 (39), 5182–5194.
   PubMed Web of Science ®Google Scholar
• Chen, J., et al., 2020a. LncRNA MST1P2/miR‐133b axis affects the chemoresistance of bladder cancer to cisplatin‐based therapy via Sirt1/p53 signaling. Journal of biochemical and molecular toxicology, 34 (4), e22452.
   PubMed Web of Science ®Google Scholar
• Chen, R., et al., 2020b. FGFRL1 affects chemoresistance of small-cell lung cancer by modulating the PI3K/Akt pathway via ENO1. Journal of cellular and molecular medicine, 24 (3), 2123–2134.
   PubMed Web of Science ®Google Scholar
• Chen, S.F., et al., 2012. Quercetin suppresses drug-resistant spheres via the p38 MAPK-Hsp27 apoptotic pathway in oral cancer cells. PLoS One, 7 (11), e49275.
   PubMed Web of Science ®Google Scholar
• Chen, S., et al., 2019. Curcumin enhances cisplatin sensitivity by suppressing NADPH oxidase 5 expression in human epithelial cancer. Oncology letters, 18 (2), 2132–2139.
   PubMed Web of Science ®Google Scholar
• Cheung, A. N., et al., 2009. Pathogenesis of choriocarcinoma: clinical, genetic and stem cell perspectives. Future oncology, 5, 217–231.
   Google Scholar
• Chou, J., et al., 2008. Nasopharyngeal carcinoma—review of the molecular mechanisms of tumorigenesis. Head & neck, 30 (7), 946–963.
   PubMed Web of Science ®Google Scholar
• Christopher, P.P., et al., 2017. Reducing therapeutic misconception: a randomized intervention trial in hypothetical clinical trials. PLoS One, 12 (9), e0184224.
   PubMed Web of Science ®Google Scholar
• Clemente-Soto, A.F., et al., 2019. Quercetin induces G2 phase arrest and apoptosis with the activation of p53 in an E6 expression-independent manner in HPV-positive human cervical cancer-derived cells. Molecular medicine reports, 19 (3), 2097–2106.
   PubMed Web of Science ®Google Scholar
• Conte, E., et al., 2020. Cisplatin-induced skeletal muscle dysfunction: mechanisms and counteracting therapeutic strategies. International journal of molecular sciences, 21 (4), 1242.
   Web of Science ®Google Scholar
• Correia, A.L. and Bissell, M.J., 2012. The tumor microenvironment is a dominant force in multidrug resistance. Drug resistance updates, 15 (1-2), 39–49.
   PubMed Web of Science ®Google Scholar
• D’Andrea, G., 2015. Quercetin: a flavonol with multifaceted therapeutic applications? Fitoterapia, 106, 256–271.
   PubMed Web of Science ®Google Scholar
• Daker, M., Ahmad, M., and Khoo, A.S., 2012. Quercetin-induced inhibition and synergistic activity with cisplatin–a chemotherapeutic strategy for nasopharyngeal carcinoma cells. Cancer cell international, 12 (1), 34.
   PubMedGoogle Scholar
• de Oliveira, M.R., et al., 2016. Quercetin and the mitochondria: a mechanistic view. Biotechnology Advances, 34 (5), 532–549.
   PubMed Web of Science ®Google Scholar
• Demiroglu-Zergeroglu, A., et al. 2010. The investigation of effects of quercetin and its combination with cisplatin on malignant mesothelioma cells in vitro. Journal of biomedicine and biotechnology, 2010, 1–7.
   Google Scholar
• Demiroglu-Zergeroglu, A., et al. 2016. Quercetin and cisplatin combined treatment altered cell cycle and mitogen activated protein kinase expressions in malignant mesotelioma cells. BMC complementary and alternative medicine, 16 (1), 281–281.
   PubMedGoogle Scholar
• Ding, Z., et al., 2000. Resistance to apoptosis is correlated with the reduced caspase-3 activation and enhanced expression of antiapoptotic proteins in human cervical multidrug-resistant cells. Biochemical and biophysical research communications, 270 (2), 415–420.
   PubMed Web of Science ®Google Scholar
• Diop-Frimpong, B., et al., .2011. Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors. Proceedings of the national academy of sciences, 108 (7), 2909–2914.
   PubMed Web of Science ®Google Scholar
• Domitrović, R., et al., 2013. Berberine exerts nephroprotective effect against cisplatin-induced kidney damage through inhibition of oxidative/nitrosative stress, inflammation, autophagy and apoptosis. Food and chemical toxicology, 62, 397–406.
   PubMed Web of Science ®Google Scholar
• dos Santos, N.A.G., Ferreira, R.S., and dos Santos, A.C., 2020. Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents. Food and chemical toxicology, 136, 111079.
   PubMed Web of Science ®Google Scholar
• Dutta, P., et al., 2020. Unphosphorylated STAT3 in heterochromatin formation and tumor suppression in lung cancer. BMC cancer, 20 (1), 145.
   PubMed Web of Science ®Google Scholar
• Eid, T. and Brines, M., 2002. Recombinant human erythropoietin for neuroprotection: what is the evidence? Clinical breast cancer, 3, S109–S115. doi:
   PubMedGoogle Scholar
• Eljack, N.D., et al., 2014. Mechanisms of cell uptake and toxicity of the anticancer drug cisplatin. Metallomics, 6 (11), 2126–2133.
   PubMed Web of Science ®Google Scholar
• Ercan, E., et al., 2014. In vitro protection of adipose tissue-derived mesenchymal stem cells by erythropoietin. Acta histochemica, 116 (1), 117–125. doi:
   PubMed Web of Science ®Google Scholar
• Fang, J., et al., 2018. Quercetin and doxorubicin co-delivery using mesoporous silica nanoparticles enhance the efficacy of gastric carcinoma chemotherapy. International journal of nanomedicine, 13, 5113–5126.
   PubMed Web of Science ®Google Scholar
• Farazi, P.A. and DePinho, R.A., 2006. Hepatocellular carcinoma pathogenesis: from genes to environment. Nature reviews cancer, 6 (9), 674–687.
   PubMed Web of Science ®Google Scholar
• Ferenczyova, K., et al., 2020. Quercetin exerts age-dependent beneficial effects on blood pressure and vascular function, but is inefficient in preventing myocardial ischemia-reperfusion injury in zucker diabetic fatty rats. Molecules, 25 (1), 187.
   Web of Science ®Google Scholar
• Ferrari, D., et al., 2020. The slippery role of induction chemotherapy in head and neck cancer: myth and reality. Frontiers in oncology, 10, 7.
   PubMed Web of Science ®Google Scholar
• Ferri, P., et al., 2015. Enhancement of flavonoid ability to cross the blood–brain barrier of rats by co-administration with α-tocopherol. Food & function, 6 (2), 394–400.
   PubMed Web of Science ®Google Scholar
• Fındık, H., et al., 2019. The protective effects of astaxanthin against cisplatin-induced retinal toxicity. Cutaneous and ocular toxicology, 38 (1), 59–65.
   PubMed Web of Science ®Google Scholar
• Francescato, H.D., et al., 2004. Protective effect of quercetin on the evolution of cisplatin-induced acute tubular necrosis. Kidney & blood pressure research, 27 (3), 148–158.
   PubMed Web of Science ®Google Scholar
• Friesland, A., et al., 2014. Amelioration of cisplatin-induced experimental peripheral neuropathy by a small molecule targeting p75NTR. Neurotoxicology, 45, 81–90.
   PubMed Web of Science ®Google Scholar
• Galluzzi, L., et al., 2012. Molecular mechanisms of cisplatin resistance. Oncogene, 31 (15), 1869–1883.
   PubMed Web of Science ®Google Scholar
• Garcia-Carbonero, R. and Paz-Ares, L., 2006. Systemic chemotherapy in the management of malignant peritoneal mesothelioma. European journal of surgical oncology, 32 (6), 676–681.
   PubMed Web of Science ®Google Scholar
• Gentilin, E., et al., 2019. Cisplatin-induced ototoxicity: updates on molecular targets. Trends in molecular medicine, 25 (12), 1123–1132.
   PubMed Web of Science ®Google Scholar
• Ghezzi, P. and Brines, M., 2004. Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell death & differentiation, 11 (S1), S37–S44.
   PubMedGoogle Scholar
• Giacomini, I., et al., 2020. The pentose phosphate pathway and its involvement in cisplatin resistance. International journal of molecular sciences, 21 (3), 937.
   Web of Science ®Google Scholar
• Gilbert, L.A. and Hemann, M.T., 2010. DNA damage-mediated induction of a chemoresistant niche. Cell, 143 (3), 355–366.
   PubMed Web of Science ®Google Scholar
• Gingras, D. and Béliveau, R., 2011. Colorectal cancer prevention through dietary and lifestyle modifications. Cancer microenvironment, 4 (2), 133–139.
   PubMedGoogle Scholar
• Giordani, B., et al., 2019. Utilizing liposomal quercetin and gallic acid in localized treatment of vaginal candida infections. Pharmaceutics, 12 (1), 9.
   PubMed Web of Science ®Google Scholar
• Green, J.A., et al., 2007. Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD005574.pub2
   Web of Science ®Google Scholar
• Gündoğdu, R., et al., 2019. Assessment of the effectiveness of quercetin on cisplatin-induced ototoxicity in rats. The journal of international advanced otology, 15 (2), 229–236.
   PubMed Web of Science ®Google Scholar
• Gupta, A., et al., 2019. Corilagin in cancer: a critical evaluation of anticancer activities and molecular mechanisms. Molecules, 24 (18), 3399.
   PubMed Web of Science ®Google Scholar
• Hallajzadeh, J., et al., 2019. The effects of curcumin supplementation on endothelial function: a systematic review and meta-analysis of randomized controlled trials. Phytotherapy research, 33 (11), 2989–2995.
   PubMed Web of Science ®Google Scholar
• Han, L., et al., 2020. Overcoming cisplatin resistance by targeting the MTDH-PTEN interaction in ovarian cancer with sera derived from rats exposed to Guizhi Fuling wan extract. BMC complementary medicine and therapies, 20 (1), 1–14.
   PubMedGoogle Scholar
• Hardie, D.G., Carling, D., and Carlson, M., 1998. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annual review of biochemistry, 67, 821–855.
   PubMed Web of Science ®Google Scholar
• Holah, N.S. and Hemida, A.S., 2020. Cyclin D1 and PSA act as good prognostic and clinicopathological indicators for breast cancer. Journal of immunoassay and immunochemistry, 41 (1), 28–44.
   PubMedGoogle Scholar
• Hu, K., et al., 2017. Quercetin remodels the tumor microenvironment to improve the permeation, retention, and antitumor effects of nanoparticles. ACS nano, 11 (5), 4916–4925.
   PubMed Web of Science ®Google Scholar
• Hu, T., et al., 2020. Quercetin protects against diabetic encephalopathy via SIRT1/NLRP3 pathway in db/db mice. Journal of cellular and molecular medicine, 24 (6), 3449–3459.
   PubMed Web of Science ®Google Scholar
• Huang, H., et al., 2020. Effect of quercetin supplementation on plasma lipid profiles, blood pressure, and glucose levels: a systematic review and meta-analysis. Nutrition reviews. doi:10.1093/nutrit/nuz071
   Web of Science ®Google Scholar
• Huebbe, P., et al., 2010. Effect of dietary quercetin on brain quercetin levels and the expression of antioxidant and Alzheimer’s disease relevant genes in mice. Pharmacological research, 61 (3), 242–246.
   PubMed Web of Science ®Google Scholar
• Hui, D., et al., .2020. Astragalus propinquus Schischkin and Panax notoginseng (A&P) compound relieved cisplatin-induced acute kidney injury through inhibiting the mincle maintained macrophage inflammation. Journal of ethnopharmacology, 252, 112637.
   PubMed Web of Science ®Google Scholar
• Hyun, H.B., Moon, J.Y., and Cho, S.K., 2018. Quercetin suppresses CYR61-mediated multidrug resistance in human gastric adenocarcinoma AGS cells. Molecules, 23 (2), 209.
   Web of Science ®Google Scholar
• Ibrahim, K.A., et al., 2020. Quercetin attenuates the oxidative injury–mediated upregulation of apoptotic gene expression and catecholaminergic neurotransmitters of the fetal rats’ brain following prenatal exposure to fenitrothion insecticide. Neurotoxicity research, 37 (4), 871–812.
   PubMed Web of Science ®Google Scholar
• Jakubowicz-Gil, J., et al., 2005. The effect of quercetin on pro-apoptotic activity of cisplatin in HeLa cells. Biochemical pharmacology, 69 (9), 1343–1350.
   PubMed Web of Science ®Google Scholar
• Jayaraman, S., et al., 2020. Abstract P6-04-06: Protein kinase C beta 1 (PKCβ1), a novel drug target of Z-endoxifen, inhibits growth of estrogen receptor positive (ER+) breast cancer via activation of the NF-kB transcription factor RelA. American association for cancer research. doi:10.1158/1538-7445.SABCS19-P6-04-06
   Google Scholar
• Jia, L., et al., 2018. Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction. Life sciences, 208, 123–130.
   PubMed Web of Science ®Google Scholar
• Jung, Y.Y., et al., 2019. Fangchinoline, a bisbenzylisoquinoline alkaloid can modulate cytokine-impelled apoptosis via the dual regulation of NF-κB and AP-1 pathways. Molecules, 24 (17), 3127.
   Web of Science ®Google Scholar
• Karasawa, T. and Steyger, P.S., 2015. An integrated view of cisplatin-induced nephrotoxicity and ototoxicity. Toxicology letters, 237 (3), 219–227.
   PubMed Web of Science ®Google Scholar
• Kim, H.S., et al., 2012. Quercetin enhances hypoxia-mediated apoptosis via direct inhibition of AMPK activity in HCT116 colon cancer. Apoptosis, 17 (9), 938–949.
   PubMed Web of Science ®Google Scholar
• Kınal, M.E., et al., 2019. Investigation of astaxanthin effect on cisplatin ototoxicity in rats by using otoacoustic emission, total antioxidant capacity, and histopathological methods. Ear, nose & throat journal, 0145561319866826.
   PubMedGoogle Scholar
• Kuhar, M., Sen, S., and Singh, N., 2006. Role of mitochondria in quercetin-enhanced chemotherapeutic response in human non-small cell lung carcinoma H-520 cells. Anticancer research, 26 (2a), 1297–1303.
   PubMed Web of Science ®Google Scholar
• Kuhlmann, M.K., et al., 1998. Reduction of cisplatin toxicity in cultured renal tubular cells by the bioflavonoid quercetin. Archives of toxicology, 72 (8), 536–540.
   PubMed Web of Science ®Google Scholar
• Kuro-o, M., 2019. The Klotho proteins in health and disease. Nature reviews. Nephrology, 15 (1), 27–44.
   PubMed Web of Science ®Google Scholar
• Kütük, S.G., et al., 2019. Curcumin enhances cisplatin-induced human laryngeal squamous cancer cell death through activation of TRPM2 channel and mitochondrial oxidative stress. Scientific reports, 9 (1), 1–14.
   PubMedGoogle Scholar
• Kwak, A.W., et al., 2019. Retrochalcone echinatin triggers apoptosis of esophageal squamous cell carcinoma via ROS- and ER stress-mediated signaling pathways. Molecules, 24 (22), 4055.
   Web of Science ®Google Scholar
• Lai, X.-N., et al., 2020. MiRNAs and LncRNAs: dual roles in TGF-β signaling-regulated metastasis in lung cancer. International journal of molecular sciences, 21 (4), 1193.
   Web of Science ®Google Scholar
• Lan, C.Y., et al., 2019. Quercetin facilitates cell death and chemosensitivity through RAGE/PI3K/AKT/mTOR axis in human pancreatic cancer cells. Journal of food and drug analysis, 27 (4), 887–896.
   PubMed Web of Science ®Google Scholar
• Langner, E., Lemieszek, M.K., and Rzeski, W., 2019. Lycopene, sulforaphane, quercetin, and curcumin applied together show improved antiproliferative potential in colon cancer cells in vitro. Journal of food biochemistry, 43 (4), e12802.
   PubMed Web of Science ®Google Scholar
• Leboeuf, D., et al., 2020. Downregulation of the Arg/N-degron pathway sensitizes cancer cells to chemotherapy in vivo. Molecular therapy, 28 (4), 1092–1104.
   PubMed Web of Science ®Google Scholar
• Lee, A.Y., et al., 2007. Update on the molecular biology of malignant mesothelioma. Cancer, 109 (8), 1454–1461.
   PubMed Web of Science ®Google Scholar
• Lee, J.H., et al., 2019. Farnesol abrogates epithelial to mesenchymal transition process through regulating Akt/mTOR pathway. Pharmacological research, 150, 104504.
   PubMed Web of Science ®Google Scholar
• Lee, S.K., et al., 2015a. Protective role of quercetin against cisplatin-induced hair cell damage in zebrafish embryos. Human & experimental toxicology, 34 (11), 1043–1052.
   PubMed Web of Science ®Google Scholar
• Lee, Y.-J., Lee, D.M., and Lee, S.-H., 2015b. Nrf2 expression and apoptosis in quercetin-treated malignant mesothelioma cells. Molecules and cells, 38 (5), 416–425.
   PubMed Web of Science ®Google Scholar
• Lesjak, M., et al., 2018. Antioxidant and anti-inflammatory activities of quercetin and its derivatives. Journal of functional foods, 40, 68–75.
   Web of Science ®Google Scholar
• Li, B., et al., 2020a. Chinese herbal formulas Miao-Yi-Ai-Tang inhibits the proliferation and migration of lung cancer cells through targeting β-Catenin/AXIN and presents synergistic effect with cisplatin suppressing lung cancer. BioMed research international, 2020, 2761850.
   PubMed Web of Science ®Google Scholar
• Li, F., et al., 2018a. The simultaneous loading of catechin and quercetin on chitosan-based nanoparticles as effective antioxidant and antibacterial agent. Food research international), 111, 351–360.
   PubMed Web of Science ®Google Scholar
• Li, J., et al., 2019a. Bortezomib promotes apoptosis of multiple myeloma cells by regulating HSP27. Molecular medicine reports, 20 (3), 2410–2418.
   PubMed Web of Science ®Google Scholar
• Li, N., et al., 2014. Low concentration of quercetin antagonizes the cytotoxic effects of anti-neoplastic drugs in ovarian cancer. PLoS One, 9 (7), e100314.
   PubMed Web of Science ®Google Scholar
• Li, Q.C., et al., 2016. Enhanced therapeutic efficacy and amelioration of cisplatin-induced nephrotoxicity by quercetin in 1,2-dimethyl hydrazine-induced colon cancer in rats. Indian journal of pharmacology, 48 (2), 168–171.
   PubMed Web of Science ®Google Scholar
• Li, S., et al., 2018b. Quercetin protects against ox-LDL-induced injury via regulation of ABCAl, LXR-α and PCSK9 in RAW264.7 macrophages. Molecular medicine reports, 18 (1), 799–806.
   PubMed Web of Science ®Google Scholar
• Li, X., et al., 2019b. Combination of quercetin and cisplatin enhances apoptosis in OSCC cells by downregulating xIAP through the NF-κB pathway. Journal of cancer, 10 (19), 4509–4521.
   PubMed Web of Science ®Google Scholar
• Li, Y., et al., 2019c. Activation of Nrf2 signaling by sitagliptin and quercetin combination against β-amyloid induced Alzheimer's disease in rats. Drug development research, 80 (6), 837–845.
   PubMed Web of Science ®Google Scholar
• Li, Z., et al., 2020b. Melatonin inhibits apoptosis in mouse Leydig cells via the retinoic acid-related orphan nuclear receptor alpha/p53 pathway. Life sciences, 246, 117431.
   PubMed Web of Science ®Google Scholar
• Lim, W., et al., 2016. Apigenin reduces survival of choriocarcinoma cells by inducing apoptosis via the PI3K/AKT and ERK1/2 MAPK pathways. Journal of cellular physiology, 231 (12), 2690–2699.
   PubMed Web of Science ®Google Scholar
• Lim, W., et al., 2017. Inhibitory effects of quercetin on progression of human choriocarcinoma cells are mediated through PI3K/AKT and MAPK signal transduction cascades. Journal of cellular physiology, 232 (6), 1428–1440. doi:10.1002/jcp.25637
   PubMed Web of Science ®Google Scholar
• Lin, X., et al., 2019. MiR-199b-5p suppresses tumor angiogenesis mediated by vascular endothelial cells in breast cancer by targeting ALK1. Frontiers in genetics, 10, 1397.
   PubMed Web of Science ®Google Scholar
• Lingling, Z., et al., 2020. Molecular regulatory network of PD-1/PD-L1 in non-small cell lung cancer. Pathology, 216 (4), 152852.
   Web of Science ®Google Scholar
• Liu, H., Lee, J.I., and Ahn, T.-G., 2019. Effect of quercetin on the anti-tumor activity of cisplatin in EMT6 breast tumor-bearing mice. Obstetrics & gynecology science, 62 (4), 242–248.
   PubMedGoogle Scholar
• Liu, X., et al., 2020. Protective and therapeutic effects of nanoliposomal quercetin on acute liver injury in rats. BMC pharmacology & toxicology, 21 (1), 11.
   PubMed Web of Science ®Google Scholar
• Long, Q., et al., 2013. Induction of apoptosis and inhibition of angiogenesis by PEGylated liposomal quercetin in both cisplatin-sensitive and cisplatin-resistant ovarian cancers. Journal of biomedical nanotechnology, 9 (6), 965–975.
   PubMed Web of Science ®Google Scholar
• Lopes, B.R.P., et al., 2020. Quercetin pentaacetate inhibits in vitro human respiratory syncytial virus adhesion. Virus research, 276, 197805.
   PubMed Web of Science ®Google Scholar
• Luo, B., et al., 2013. Erythropoietin is a hypoxia inducible factor-induced protective molecule in experimental autoimmune neuritis. Biochimica et biophysica acta, 1832 (8), 1260–1270. doi:
   PubMed Web of Science ®Google Scholar
• Lurain, J.R., 2011. Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia. American journal of obstetrics and gynecology, 204 (1), 11–18.
   PubMed Web of Science ®Google Scholar
• Lv, Q., et al., 2020. Quercetin, a pneumolysin inhibitor, protects mice against Streptococcus pneumoniae infection. Microbial pathogenesis, 140, 103934.
   PubMed Web of Science ®Google Scholar
• Maciejczyk, A. and Surowiak, P., 2013. Quercetin inhibits proliferation and increases sensitivity of ovarian cancer cells to cisplatin and paclitaxel. Ginekologia polska, 84 (7), 590–595.
   PubMed Web of Science ®Google Scholar
• Mahalaxmi, I., et al., 2019. New insight into NANOG: a novel therapeutic target for ovarian cancer (OC). European journal of pharmacology, 852, 51–57. doi:
   PubMed Web of Science ®Google Scholar
• Malvezzi, M., et al., 2016. European cancer mortality predictions for the year 2016 with focus on leukaemias. Annals of oncology, 27 (4), 725–731.
   PubMed Web of Science ®Google Scholar
• Marciano, R., et al., 2020. The amuvatinib derivative, N-(2H-1,3-Benzodioxol-5-yl)-4-{thieno[3,2-d]pyrimidin-4-yl}piperazine-1-carboxami de, inhibits mitochondria and kills tumor cells under glucose starvation. International journal of molecular sciences, 21 (3). doi:10.3390/ijms21031041
   PubMed Web of Science ®Google Scholar
• Marshak, T., et al., 2014. Prevention of cisplatin-induced hearing loss by intratympanic dexamethasone: a randomized controlled study. Otolaryngology–head and neck surgery, 150 (6), 983–990.
   PubMed Web of Science ®Google Scholar
• Martínez-Martínez, D., et al., 2019. Resveratrol promotes apoptosis through the induction of dual specificity phosphatase 1 and sensitizes prostate cancer cells to cisplatin. Food and chemical toxicology, 124, 273–279.
   PubMed Web of Science ®Google Scholar
• Matuszyk, J. and Klopotowska, D., 2020. miR-125b lowers sensitivity to apoptosis following mitotic arrest: implications for breast cancer therapy. Journal of cellular physiology. doi:10.1002/jcp.29610
   PubMed Web of Science ®Google Scholar
• Meng, H., et al., 2013. Two-wave nanotherapy to target the stroma and optimize gemcitabine delivery to a human pancreatic cancer model in mice. ACS nano, 7 (11), 10048–10065.
   PubMed Web of Science ®Google Scholar
• Meng, J., et al., 2020. ID1 confers cancer cell chemoresistance through STAT3/ATF6-mediated induction of autophagy. Cell death & disease, 11 (2), 137.
   PubMed Web of Science ®Google Scholar
• Miao, L., et al., 2015. Nanoparticle modulation of the tumor microenvironment enhances therapeutic efficacy of cisplatin. Journal of controlled release, 217, 27–41.
   PubMed Web of Science ®Google Scholar
• Milanezi, F.G., et al., 2019. Antioxidant, antimicrobial and cytotoxic activities of gold nanoparticles capped with quercetin. Saudi pharmaceutical journal, 27 (7), 968–974.
   PubMed Web of Science ®Google Scholar
• Min, Z., et al., 2019. Quercetin inhibition of myocardial fibrosis through regulating MAPK signaling pathway via ROS. Pakistan journal of pharmaceutical sciences, 32 (3), 1355–1359.
   PubMed Web of Science ®Google Scholar
• Morgan, E.L. and Macdonald, A., 2019. JAK2 inhibition impairs proliferation and sensitises cervical cancer cells to cisplatin-induced cell death. Cancers, 11 (12), 1934.
   PubMed Web of Science ®Google Scholar
• Mukherjea, D. and Rybak, L.P., 2011. Pharmacogenomics of cisplatin-induced ototoxicity. Pharmacogenomics, 12 (7), 1039–1050.
   PubMed Web of Science ®Google Scholar
• Nabavi, S.F., et al., 2015. Role of quercetin as an alternative for obesity treatment: you are what you eat!. Food chemistry, 179, 305–310.
   PubMed Web of Science ®Google Scholar
• Nessa, M.U., et al., 2011. Synergism from combinations of cisplatin and oxaliplatin with quercetin and thymoquinone in human ovarian tumour models. Anticancer Research, 31 (11), 3789–3797.
   PubMed Web of Science ®Google Scholar
• Niehrs, C. and Acebron, S.P., 2012. Mitotic and mitogenic Wnt signalling. The EMBO journal, 31 (12), 2705–2713.
   PubMed Web of Science ®Google Scholar
• Nishimura, K., et al., 2017. Effect of quercetin on cell protection via erythropoietin and cell injury of HepG2 cells. Archives of biochemistry and biophysics, 636, 11–16.
   PubMed Web of Science ®Google Scholar
• Noronha, V., et al., 2020. Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer. Oncotarget, 11 (4), 399–408.
   PubMedGoogle Scholar
• Oršolić, N. and Car, N., 2014. Quercetin and hyperthermia modulate cisplatin-induced DNA damage in tumor and normal tissues in vivo. Tumour biology, 35 (7), 6445–6454.
   PubMed Web of Science ®Google Scholar
• Paganin-Gioanni, A., et al., 2020. Cyclin B1 knockdown mediated by clinically approved pulsed electric fields siRNA delivery induces tumor regression in murine melanoma. International journal of pharmaceutics, 573, 118732. doi:
   PubMed Web of Science ®Google Scholar
• Park, D.-J., et al. 2020. Quercetin attenuates decrease of thioredoxin expression following focal cerebral ischemia and glutamate-induced neuronal cell damage. Neuroscience, 428, 38–49.
   PubMed Web of Science ®Google Scholar
• Park, D.-J., et al., 2019a. Quercetin alleviates the injury-induced decrease of protein phosphatase 2A subunit B in cerebral ischemic animal model and glutamate-exposed HT22 cells. The journal of veterinary medical science, 81 (7), 1047–0094.
   PubMed Web of Science ®Google Scholar
• Park, W., et al., 2019b. Inhibitory effects of osthole on human breast cancer cell progression via induction of cell cycle arrest, mitochondrial dysfunction, and ER stress. Nutrients, 11 (11), 2777.
   PubMed Web of Science ®Google Scholar
• Parkin, D.M., et al., 2005. Global cancer statistics, 2002. CA: a cancer journal for clinicians, 55 (2), 74–108.
   PubMed Web of Science ®Google Scholar
• Pasello, G. and Favaretto, A., 2009. Molecular targets in malignant pleural mesothelioma treatment. Current drug targets, 10 (12), 1235–1244.
   PubMed Web of Science ®Google Scholar
• Peng, L., et al., 2020. Effect of tartary buckwheat, rutin, and quercetin on lipid metabolism in rats during high dietary fat intake. Food science & nutrition, 8 (1), 199–213.
   PubMed Web of Science ®Google Scholar
• Qin, L., et al., 2020. A novel tumour suppressor lncRNA F630028O10Rik inhibits lung cancer angiogenesis by regulating miR-223-3p. Journal of cellular and molecular medicine, 24 (6), 3549–3559.
   PubMed Web of Science ®Google Scholar
• Rabiee, S., et al., 2019. Autophagic, apoptotic, and necrotic cancer cell fates triggered by acidic pH microenvironment. Journal of cellular physiology, 234 (7), 12061–12069.
   PubMed Web of Science ®Google Scholar
• Rachakhom, W., et al., 2019. Dihydrochalcone derivative induces breast cancer cell apoptosis via intrinsic, extrinsic, and er stress pathways but abolishes EGFR/MAPK Pathway. BioMed research international, 2019, 7298539.
   PubMed Web of Science ®Google Scholar
• Ren, S., et al., 2010. Quercetin permeability across blood-brain barrier and its effect on the viability of U251 cells. Sichuan da xue xue bao, 41 (5), 751–754.
   PubMedGoogle Scholar
• Revaux, A., et al., 2020. Hyperthermic intraperitoneal chemotherapy in ovarian cancer: an update. Hormone molecular biology and clinical investigation. doi:10.1515/hmbci-2019-0028
   PubMedGoogle Scholar
• Rjiba-Touati, K., et al., 2013. Antioxidant and antigenotoxic role of recombinant human erythropoeitin against alkylating agents: Cisplatin and mitomycin C in cultured Vero cells. Experimental biology and medicine), 238 (8), 943–950.
   Web of Science ®Google Scholar
• Rodriguez-Ruiz, M.E., et al., 2019. Apoptotic caspases inhibit abscopal responses to radiation and identify a new prognostic biomarker for breast cancer patients. Oncoimmunology, 8 (11), e1655964.
   PubMed Web of Science ®Google Scholar
• Rybak, L.P., 2007. Mechanisms of cisplatin ototoxicity and progress in otoprotection. Current opinion in otolaryngology & head and neck surgery, 15 (5), 364–369.
   PubMedGoogle Scholar
• Rybak, L.P., et al., 2000. Effect of protective agents against cisplatin ototoxicity. American journal of otolaryngology, 21 (4), 513–520.
   Google Scholar
• Salehi, M., et al., in press. Therapeutic potentials of curcumin in the treatment of non-small-cell lung carcinoma. Phytotherapy research.doi:10.1002/ptr.6704
   Web of Science ®Google Scholar
• Sanagoo, A., et al., 2020. A systematic review and meta-analysis on the association of serum and tumor tissue iron and risk of breast cancer. Caspian journal of internal medicine, 11 (1), 1–11.
   PubMed Web of Science ®Google Scholar
• Sánchez-González, P.D., et al., 2017. Differential effect of quercetin on cisplatin-induced toxicity in kidney and tumor tissues. Food and chemical toxicology, 107, 226–236.
   PubMed Web of Science ®Google Scholar
• Sanchez-Gonzalez, P.D., et al., 2011. Quercetin reduces cisplatin nephrotoxicity in rats without compromising its anti-tumour activity. Nephrology, dialysis, transplantation, 26 (11), 3484–3495.
   PubMed Web of Science ®Google Scholar
• Scambia, G., et al., 1990. Synergistic antiproliferative activity of quercetin and cisplatin on ovarian cancer cell growth. Anti-cancer drugs, 1 (1), 45–48.
   PubMedGoogle Scholar
• Sebolt-Leopold, J.S. and Herrera, R., 2004. Targeting the mitogen-activated protein kinase cascade to treat cancer. Nature reviews cancer, 4 (12), 937–947.
   PubMed Web of Science ®Google Scholar
• Shao, Y., et al., 2019. A solid dispersion of quercetin shows enhanced Nrf2 activation and protective effects against oxidative injury in a mouse model of dry age-related macular degeneration. Oxidative medicine and cellular longevity, 2019, 1479571.
   PubMed Web of Science ®Google Scholar
• Sharma, H., Sen, S., and Singh, N., 2005. Molecular pathways in the chemosensitization of cisplatin by quercetin in human head and neck cancer. Cancer biology & therapy, 4 (9), 949–955.
   PubMed Web of Science ®Google Scholar
• Sharma, R., et al., 2017. Glycyrrhiza glabra extract and quercetin reverses cisplatin resistance in triple-negative MDA-MB-468 breast cancer cells via inhibition of cytochrome P450 1B1 enzyme. Bioorganic & medicinal chemistry letters, 27 (24), 5400–5403.
   PubMed Web of Science ®Google Scholar
• Shen, F. and Weber, G., 1997. Synergistic action of quercetin and genistein in human ovarian carcinoma cells. Oncology research, 9 (11-12), 597–602.
   PubMed Web of Science ®Google Scholar
• Shih, I.-M., 2007. Gestational trophoblastic neoplasia—pathogenesis and potential therapeutic targets. The lancet oncology, 8 (7), 642–650.
   PubMed Web of Science ®Google Scholar
• Singh, A.K., et al., 2020. Quercetin and coumarin inhibit dipeptidyl peptidase-iv and exhibits antioxidant properties: in silico. Biomolecules, 10 (2), 207.
   Web of Science ®Google Scholar
• Sioud, F., et al., 2020. A new highlight of ephedra alata decne properties as potential adjuvant in combination with cisplatin to induce cell death of 4t1 breast cancer cells in vitro and in vivo. Cells, 9 (2), 362.
   Web of Science ®Google Scholar
• Song, N., Thaiss, F., and Guo, L., 2019. NFκB and Kidney Injury. Frontiers in immunology, 10, 815.
   PubMed Web of Science ®Google Scholar
• Sousa, D.P., et al., 2020. Nobiletin alone or in combination with cisplatin decreases the viability of anaplastic thyroid cancer cell lines. Nutrition and cancer, 72 (2), 352–363.
   PubMed Web of Science ®Google Scholar
• Spano, J.-P., et al. 2003. Nasopharyngeal carcinomas: an update. European journal of cancer,39 (15), 2121–2135.
   PubMed Web of Science ®Google Scholar
• Srivastava, N.S. and Srivastava, R.A.K., 2019. Curcumin and quercetin synergistically inhibit cancer cell proliferation in multiple cancer cells and modulate Wnt/β-catenin signaling and apoptotic pathways in A375 cells. Phytomedicine, 52, 117–128.
   PubMed Web of Science ®Google Scholar
• Stumpf, U., et al., 2020. Incidence of fractures in patients with type 1 diabetes mellitus-a retrospective study with 4420 patients. Osteoporosis international. doi:10.1007/s00198-020-05344-w
   Google Scholar
• Su, X., et al., 2020. Inhibition of TRIM32 induced by miR-519d increases the sensitivity of colorectal cancer cells to cisplatin. Oncotargets and therapy, 13, 277–289.
   PubMed Web of Science ®Google Scholar
• Tan, R.Z., et al., 2020. Quercetin protects against cisplatin-induced acute kidney injury by inhibiting Mincle/Syk/NF-κB signaling maintained macrophage inflammation. Phytotherapy resarch, 34 (1), 139–152.
   PubMed Web of Science ®Google Scholar
• Tao, Q. and Chan, A.T., 2007. Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Expert reviews in molecular medicine, 9 (12), 1–24.
   PubMedGoogle Scholar
• Tavakol, S., et al., 2017. Organelles and chromatin fragmentation of human umbilical vein endothelial cell influence by the effects of zeta potential and size of silver nanoparticles in different manners. Artificial cells, nanomedicine, and biotechnology, 45 (4), 817–823.
   PubMed Web of Science ®Google Scholar
• Tavakol, S., et al., 2019. The impact of the particle size of curcumin nanocarriers and the ethanol on beta_1-integrin overexpression in fibroblasts: a regenerative pharmaceutical approach in skin repair and anti-aging formulations. DARU, 27 (1), 159–168.
   PubMed Web of Science ®Google Scholar
• Teekaraman, D., et al., 2019. Quercetin inhibits human metastatic ovarian cancer cell growth and modulates components of the intrinsic apoptotic pathway in PA-1-cell line. Chemico-biological interactions, 300, 91–100.
   PubMed Web of Science ®Google Scholar
• Terao, J., 2017. Factors modulating bioavailability of quercetin-related flavonoids and the consequences of their vascular function. Biochemical pharmacology, 139, 15–23.
   PubMed Web of Science ®Google Scholar
• Tian, H., et al., 2019a. ERas enhances resistance to cisplatin-induced apoptosis by suppressing autophagy in gastric cancer cell. Frontiers in cell and developmental biology, 7, 375.
   PubMed Web of Science ®Google Scholar
• Tian, L., et al., 2019b. Taurine up-regulated 1 accelerates tumorigenesis of colon cancer by regulating miR-26a-5p/MMP14/p38 MAPK/Hsp27 axis in vitro and in vivo. Life sciences, 239, 117035.
   PubMed Web of Science ®Google Scholar
• Tian, S., et al., 2020. SERPINH1 regulates EMT and gastric cancer metastasis via the Wnt/beta-catenin signaling pathway. Aging, 12 (4), 3574–3593.
   PubMedGoogle Scholar
• Trédan, O., et al., 2007. Drug resistance and the solid tumor microenvironment. Journal of the national cancer institute, 99 (19), 1441–1454.
   PubMed Web of Science ®Google Scholar
• Turan, C., et al., 2019. Cisplatin ototoxicity in children: risk factors and its relationship with polymorphisms of DNA repair genes ERCC1, ERCC2, and XRCC1. Cancer chemotherapy and pharmacology, 84 (6), 1333–1338.
   PubMed Web of Science ®Google Scholar
• Ueda, S., et al., 2020. miR-27a ameliorates chemoresistance of breast cancer cells by disruption of reactive oxygen species homeostasis and impairment of autophagy. Laboratory investigation. doi:10.1038/s41374-020-0409-4
   PubMed Web of Science ®Google Scholar
• Vafadar, A., et al., 2020. Quercetin and cancer: new insights into its therapeutic effects on ovarian cancer cells. Cell & bioscience, 10 (1), 32.
   PubMed Web of Science ®Google Scholar
• Vickers, N.J., 2017. Animal communication: when I'm calling you, will you answer too? Current biology, 27 (14), R713–R715.
   PubMed Web of Science ®Google Scholar
• Wang, L., et al., 2019a. Quercetin protects rats from catheter-related Staphylococcus aureus infections by inhibiting coagulase activity. Journal of cellular and molecular medicine, 23 (7), 4808–4818.
   PubMed Web of Science ®Google Scholar
• Wang, M., et al., 2019b. miR-152-3p sensitizes glioblastoma cells towards cisplatin via regulation of SOS1. Oncotargets and therapy, 12, 9513–9525.
   PubMed Web of Science ®Google Scholar
• Wang, Q., et al., 2020a. Quercetin radiosensitizes non-small cell lung cancer cells through the regulation of miR-16-5p/WEE1 axis. IUBMB life, 72 (5), 1012–1022.
   PubMed Web of Science ®Google Scholar
• Wang, W., et al., 2020b. Sphingosine 1-phosphate receptor 2 induces otoprotective responses to cisplatin treatment. Cancers, 12 (1), 211.
   Web of Science ®Google Scholar
• Wang, X., et al., 2020c. Cisplatin resistance in gastric cancer cells is involved with GPR30‐mediated epithelial‐mesenchymal transition. Journal of cellular and molecular medicine, 24 (6), 3625–3633.
   PubMed Web of Science ®Google Scholar
• Wang, Y., et al., 2015. The cranberry flavonoids PAC DP-9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cells. International journal of oncology, 46 (5), 1924–1934.
   PubMed Web of Science ®Google Scholar
• Waseem, M., et al., 2017. Ameliorative efficacy of quercetin against cisplatin-induced mitochondrial dysfunction: study on isolated rat liver mitochondria. Molecular medicine reports, 16 (3), 2939–2945.
   PubMed Web of Science ®Google Scholar
• Weiner, S.J. and Neragi-Miandoab, S., 2009. Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors. Journal of cancer research and clinical Oncology, 135 (1), 15–27.
   PubMed Web of Science ®Google Scholar
• Wen, P., et al. 2018. Preparation and characterization of electrospun colon-specific delivery system for quercetin and its antiproliferative effect on cancer cells. Journal of agricultural and food chemistry, 66 (44), 11550–11559.
   PubMed Web of Science ®Google Scholar
• Wu, B., et al., 2012. Icariin improves cognitive deficits and activates quiescent neural stem cells in aging rats. Journal of ethnopharmacology, 142 (3), 746–753.
   PubMed Web of Science ®Google Scholar
• Wu, M., Liu, F., and Guo, Q., 2019. Quercetin attenuates hypoxia-ischemia induced brain injury in neonatal rats by inhibiting TLR4/NF-κB signaling pathway. International immunopharmacology, 74, 105704.
   PubMed Web of Science ®Google Scholar
• Wu, S., et al., 2020a. miR-492 promote chemoresistance to CDDP and metastasis by targeting inhibiting DNMT3B and induce stemness in gastric cancer. Bioscience reports, 40 (3). doi:10.1042/BSR20194342
   Google Scholar
• Wu, Y., et al., 2020b. Polyphyllin I activates AMPK to suppress the growth of non-small-cell lung cancer via induction of autophagy. Archives of biochemistry and biophysics, 687, 108285.
   PubMed Web of Science ®Google Scholar
• Xiao, F., et al., 2020. Trim14 promotes autophagy and chemotherapy resistance of gastric cancer cells by regulating AMPK/mTOR pathway. Drug development research. doi:10.1002/ddr.21650
   PubMed Web of Science ®Google Scholar
• Xiao, L., et al., 2018. Quercetin and iron metabolism: what we know and what we need to know. Food and chemical toxicology, 114, 190–203.
   PubMed Web of Science ®Google Scholar
• Xing, Y., et al., 2020. Mitochondria-targeting zeolitic imidazole frameworks to overcome platinum-resistant ovarian cancer. Colloids and surfaces. B, biointerfaces, 189, 110837.
   PubMed Web of Science ®Google Scholar
• Xu, J., et al., 2020. Cucurbitacin B inhibits gastric cancer progression by suppressing STAT3 activity. Archives of biochemistry and biophysics, 684, 108314.
   PubMed Web of Science ®Google Scholar
• Xu, M., et al., 2019. FOXD3, frequently methylated in colorectal cancer, acts as a tumor suppressor and induces tumor cell apoptosis under ER stress via p53. Carcinogenesis. doi:10.1093/carcin/bgz198
   Google Scholar
• Xue, D.F., et al., 2020. ROS enhances the cytotoxicity of cisplatin by inducing apoptosis and autophagy in tongue squamous cell carcinoma cells. The international journal of biochemistry & cell biology, 122, 105732.
   PubMed Web of Science ®Google Scholar
• Yang, J.X., et al., 2020a. Quercetin improves immune function in arbor acre broilers through activation of NF-kappaB signaling pathway. Poultry science, 99 (2), 906–913.
   PubMed Web of Science ®Google Scholar
• Yang, S., et al., 2020b. Quercetin is protective against short-term dietary advanced glycation end products intake induced cognitive dysfunction in aged ICR mice. Journal of food biochemistry, 44 (4). doi:10.1111/jfbc.13164
   Web of Science ®Google Scholar
• Yang, W., et al., 2020c. miR-1269b drives cisplatin resistance of human non-small cell lung cancer via modulating the PTEN/PI3K/AKT signaling pathway. Oncotargets and therapy, 13, 109–118.
   PubMed Web of Science ®Google Scholar
• Yang, Y., et al., 2019a. MiR-214 sensitizes human colon cancer cells to 5-FU by targeting Hsp27. Cellular & molecular biology letters, 24, 22.
   PubMed Web of Science ®Google Scholar
• Yang, Y., et al., 2019b. Quercetin preferentially induces apoptosis in KRAS-mutant colorectal cancer cells via JNK signaling pathways. Cell biology international, 43 (2), 117–124.
   PubMed Web of Science ®Google Scholar
• Yang, Z., et al., 2015. Quercetin induces endoplasmic reticulum stress to enhance cDDP cytotoxicity in ovarian cancer: involvement of STAT3 signaling. The FEBS journal, 282 (6), 1111–1125.
   PubMed Web of Science ®Google Scholar
• Yashiro, M., et al., 2009. Epigenetic regulation of the embryonic oncogene ERas in gastric cancer cells. International journal of oncology, 35 (5), 997–1003.
   PubMed Web of Science ®Google Scholar
• Yorozu, A., et al., 2020. Upregulation of AEBP1 in endothelial cells promotes tumor angiogenesis in colorectal cancer. Cancer science, 111 (5), 1631–1644.
   PubMed Web of Science ®Google Scholar
• You, F., et al., 2020. miR106a promotes the growth of transplanted breast cancer and decreases the sensitivity of transplanted tumors to cisplatin. Cancer management and research, 12, 233–246.
   PubMed Web of Science ®Google Scholar
• Zaplatic, E., et al., 2019. Molecular mechanisms underlying protective role of quercetin in attenuating Alzheimer’s disease. Life Sciences, 224, 109–119.
   PubMed Web of Science ®Google Scholar
• Zhang, C., et al. 2020a. Circular RNA in Lung Cancer Research: Biogenesis, Functions, and Roles. International Journal of biological sciences, 16 (5), 803–814.
   PubMed Web of Science ®Google Scholar
• Zhang, L. and Guo, Y., 2020. Silencing circular RNA-ZNF652 represses proliferation and EMT process of renal carcinoma cells via raising miR-205. Artificial cells, nanomedicine, and biotechnology, 48 (1), 648–655.
   PubMed Web of Science ®Google Scholar
• Zhang, X., et al., 2015. Quercetin enhances cisplatin sensitivity of human osteosarcoma cells by modulating microRNA-217-KRAS axis. Molecules and cells, 38 (7), 638–642.
   PubMed Web of Science ®Google Scholar
• Zhang, X., et al., 2020b. Quercetin enhanced paclitaxel therapeutic effects towards PC-3 prostate cancer through ER stress induction and ROS production. Oncotargets and therapy, 13, 513–523.
   PubMed Web of Science ®Google Scholar
• Zhang, X., et al., 2018. Quantitation of β-carboline and quercetin in alligator weed (Alternanthera philoxeroides (Mart.) Griseb.) by LC-MS/MS and evaluation of cardioprotective effects of the methanol extracts. Drug discoveries & therapeutics, 12 (6), 341–346.
   PubMed Web of Science ®Google Scholar
• Zhao, J., et al., 2019. Quercetin inhibits cell viability, migration and invasion by regulating miR-16/HOXA10 axis in oral cancer. European journal of pharmacology, 847, 11–18.
   PubMed Web of Science ®Google Scholar
• Zhao, J.L., Zhao, J., and Jiao, H.J., 2014. Synergistic growth-suppressive effects of quercetin and cisplatin on HepG2 human hepatocellular carcinoma cells. Applied biochemistry and biotechnology, 172 (2), 784–791.
   PubMed Web of Science ®Google Scholar
• Zhao, P., et al., 2020. Quercetin alleviates hyperthyroidism-induced liver damage via Nrf2 Signaling pathway. Biofactors. doi:10.1002/biof.1626
   Web of Science ®Google Scholar
• Zheng, G., et al2018. HSP27-mediated extracellular and intracellular signaling pathways synergistically confer chemoresistance in squamous cell carcinoma of tongue. Clinical cancer research, 24 (5), 1163–1175.
   PubMed Web of Science ®Google Scholar
• Zheng, H., et al., 2020. Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells. World journal of gastroenterology, 26 (5), 499–513.
   PubMed Web of Science ®Google Scholar
• Zhong, Z. and Virshup, D.M., 2020. Wnt signaling and drug resistance in cancer. Molecular pharmacology, 97 (2), 72–89.
   PubMed Web of Science ®Google Scholar
• Zwicker, J.I., et al., 2019. Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer. JCI insight, 4 (4). doi:10.1172/jci.insight.125851
   PubMed Web of Science ®Google Scholar